PMC:7377212 / 16170-16307 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T41","span":{"begin":8,"end":13},"obj":"Body_part"}],"attributes":[{"id":"A41","pred":"fma_id","subj":"T41","obj":"http://purl.org/sig/ont/fma/fma63083"}],"text":"mortem, serum GM had only 25% sensitivity in those that were not neutropenic (versus 70% in neutropenic patients) [31]. In contrast, BAL "}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T38","span":{"begin":8,"end":13},"obj":"Body_part"}],"attributes":[{"id":"A38","pred":"uberon_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"mortem, serum GM had only 25% sensitivity in those that were not neutropenic (versus 70% in neutropenic patients) [31]. In contrast, BAL "}

{"project":"LitCovid-PubTator","denotations":[{"id":"523","span":{"begin":104,"end":112},"obj":"Species"},{"id":"526","span":{"begin":14,"end":16},"obj":"Chemical"}],"attributes":[{"id":"A523","pred":"tao:has_database_id","subj":"523","obj":"Tax:9606"},{"id":"A526","pred":"tao:has_database_id","subj":"526","obj":"MESH:C012990"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"mortem, serum GM had only 25% sensitivity in those that were not neutropenic (versus 70% in neutropenic patients) [31]. In contrast, BAL "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T240","span":{"begin":14,"end":16},"obj":"Chemical"},{"id":"T242","span":{"begin":133,"end":136},"obj":"Chemical"}],"attributes":[{"id":"A240","pred":"chebi_id","subj":"T240","obj":"http://purl.obolibrary.org/obo/CHEBI_74120"},{"id":"A241","pred":"chebi_id","subj":"T240","obj":"http://purl.obolibrary.org/obo/CHEBI_27680"},{"id":"A242","pred":"chebi_id","subj":"T242","obj":"http://purl.obolibrary.org/obo/CHEBI_64198"}],"text":"mortem, serum GM had only 25% sensitivity in those that were not neutropenic (versus 70% in neutropenic patients) [31]. In contrast, BAL "}

{"project":"MyTest","denotations":[{"id":"32703771-17885264-29390913","span":{"begin":115,"end":117},"obj":"17885264"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"mortem, serum GM had only 25% sensitivity in those that were not neutropenic (versus 70% in neutropenic patients) [31]. In contrast, BAL "}

{"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T21","span":{"begin":14,"end":16},"obj":"GlycoEpitope"}],"attributes":[{"id":"A21","pred":"glyco_epitope_db_id","subj":"T21","obj":"http://www.glycoepitope.jp/epitopes/EP0510"}],"text":"mortem, serum GM had only 25% sensitivity in those that were not neutropenic (versus 70% in neutropenic patients) [31]. In contrast, BAL "}

{"project":"2_test","denotations":[{"id":"32703771-17885264-29390913","span":{"begin":115,"end":117},"obj":"17885264"}],"text":"mortem, serum GM had only 25% sensitivity in those that were not neutropenic (versus 70% in neutropenic patients) [31]. In contrast, BAL "}